Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?The Motley Fool • 10/18/23
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for InvestorsThe Motley Fool • 10/17/23
J&J Beats Profit Estimates on Pharmaceutical, Medtech Sales as COVID-19 Shot Revenue SlowsInvestopedia • 10/17/23
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats ViewsInvestors Business Daily • 10/17/23
Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit HardThe Motley Fool • 10/17/23
Johnson & Johnson (JNJ) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 10/17/23
J&J's stock rallies after profit and sales rise above expectations, full-year outlook increasedMarket Watch • 10/17/23
Johnson & Johnson's 3Q earnings in spotlight next week following Kenvue splitProactive Investors • 10/13/23